ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $442 | -99.5% | 71,000 | +305.7% | 0.70% | +445.3% |
| Q1 2022 | $81,000 | -67.9% | 17,500 | -65.3% | 0.13% | -60.6% |
| Q4 2021 | $252,000 | -16.3% | 50,500 | +573.3% | 0.32% | +112.4% |
| Q1 2019 | $301,000 | +48.3% | 7,500 | -63.4% | 0.15% | +40.4% |
| Q2 2016 | $203,000 | -63.6% | 20,500 | -37.9% | 0.11% | -33.1% |
| Q1 2016 | $558,000 | -51.8% | 33,000 | -36.5% | 0.16% | -58.5% |
| Q4 2015 | $1,158,000 | – | 52,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |